NCT04098926View on ClinicalTrials.gov

Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

July 13, 2018

Conditions
Breast CancerRadiotherapy
Interventions
RADIATION

Dose-integrated accelerated EBRT in pN0 breast cancer

WBI: 5 x 5.7Gy Thoracic wall: 5 x 5.7Gy R0 boost: 5 x 6.5Gy R1 boost: 5 x 6.9Gy

RADIATION

Dose-integrated accelerated EBRT in pN+ breast cancer

WBI: 5 x 5.7Gy Thoracic wall: 5 x 5.7Gy R0 boost: 5 x 6.5Gy R1 boost: 5 x 6.9Gy Lymph node region: 5 x 5.4Gy

Trial Locations (1)

9000

University Hospital - Radiotherapy Department, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT04098926 - Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer | Biotech Hunter | Biotech Hunter